首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1544666

居家照護測試市場、機會、成長動力、產業趨勢分析與預測，2024-2032

Home Care Testing Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: 2024年07月11日 | 出版商:

Global Market Insights Inc. | 英文 100 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

由於產品發布激增及其與健康應用的整合，家庭護理測試市場規模預計從 2024 年到 2032 年將以 6.8% 的複合年成長率擴大。

為了滿足不斷成長的需求，該公司正在推出與各種健康應用程式無縫連接的新型家庭測試設備。這些技術進步使個人能夠在舒適的家中更輕鬆、更精確地監測自己的健康狀況。這些進步不僅促進了即時健康追蹤，還為個性化護理鋪平了道路，刺激了該行業的進一步創新和採用。例如，2023 年 10 月，PHASE Scientific Americas 推出了 INDICAID Health™ 家用測試套件以及數位健康平台。這項最新產品旨在與數位工具整合，使用戶能夠在家中有效地進行測試並管理自己的健康狀況。

整個市場分為產品類型、測試類型、樣品、配銷通路和區域。

根據產品類型，預計從 2024 年到 2032 年，測試面板領域的家庭護理測試市場價值將大幅成長。為此，該公司正在製作先進的測試面板，使個人能夠在家中進行各種診斷。這些測試面板富含多種生物標記物，可提供全面的健康見解，簡化使用者的狀況監測和健康追蹤。

預計到 2032 年，線上藥局配銷通路領域的家庭護理測試行業規模將以複合年成長率大幅成長。分銷的數位化轉變不僅簡化了家庭護理測試產品的採購，還提高了使用者的便利性和效率。為了進一步提高可及性，線上藥局正在採用即時庫存更新、個人化推薦和直接送貨上門等功能。

從地區來看，由於人口老化和慢性病的增加，預計 2024 年至 2032 年間歐洲家庭護理測試市場規模將出現顯著的複合年成長率。隨著慢性病變得越來越普遍，對定期家庭檢測和管理的需求不斷增加。作為回應，公司正在微調他們的居家護理測試產品，確保使用者擁有輕鬆進行健康監測所需的工具。此外，隨著複雜測試技術的進步以及與數位健康平台的增強整合，該地區的個人能夠更好地主動管理自己的健康。

產業生態系統分析
產業影響力
- 成長動力
  - 慢性病盛行率增加
  - 對現場檢測的需求不斷成長
  - 產品技術進步
- 產業陷阱與挑戰
  - 成本高
成長潛力分析
監管環境
2023 年定價分析
技術景觀
波特的分析
PESTEL分析
未來市場趨勢
差距分析

第 4 章：競爭格局

介紹
公司矩陣分析
公司市佔率分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按產品類型，2021 - 2032

主要趨勢
條
卡式磁帶
測試板
中游
浸卡
其他產品類型

第 6 章：市場估計與預測：按測試類型，2021 - 2032

主要趨勢
傳染病
糖尿病和葡萄糖
愛滋病
懷孕
膽固醇和三酸甘油酯
泌尿道感染
其他測試類型

第 7 章：市場估計與預測：按樣本，2021 - 2032 年

主要趨勢
血
尿
唾液
其他樣品

第 8 章：市場估計與預測：按配銷通路分類，2021 - 2032 年

主要趨勢
零售藥局
醫院藥房
網路藥局
其他分銷管道

第 9 章：市場估計與預測：按地區，2021 - 2032

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 荷蘭
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 沙烏地阿拉伯
- 南非
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 10 章：公司簡介

Abbott
ACON Laboratories, Inc.
Ascensia Diabetes Care Holdings AG
BD
bioLytical Laboratories Inc.
BioSure
Cardinal Health
Chembio Diagnostics, Inc
F. Hoffmann-La Roche Ltd.
LifeScan IP Holdings, LLC
MP BIOMEDICALS
Nova Biomedical
OraSure Technologies, Inc.
Quidel Corp.
SA Scientific Ltd
Siemens Healthcare GmbH
Sterilab Services

簡介目錄

Product Code: 10201

Home Care Testing Market size is projected to expand at a 6.8% CAGR from 2024 to 2032, due to the surge in product launches and their integration with health applications.

In response to the rising demands, companies are unveiling new home testing devices that seamlessly interface with various health applications. These technological strides empower individuals to monitor their health with greater ease and precision, all from the comfort of their homes. Such advancements not only facilitate real-time health tracking but also pave the way for personalized care, spurring further innovation and adoption in the sector. For instance, in October 2023, PHASE Scientific Americas rolled out the INDICAID Health(TM) at-home test kits, coupled with a digital health platform. This latest offering, designed to integrate with digital tools, empowers users to efficiently conduct tests and manage their health from home.

The overall market is segregated into product type, test type, sample, distribution channel, and region.

Based on product type, the home care testing market value from the test panel segment is estimated to rise at a substantial rate from 2024 to 2032. This surge is attributed to the rising demand for diverse health solutions. In response, companies are crafting advanced test panels, allowing individuals to conduct a wide array of diagnostics from home. These test panels, enriched with multiple biomarkers, offer holistic health insights, simplifying condition monitoring and wellness tracking for users.

Home care testing industry size from the online pharmacies distribution channel segment is anticipated to grow at a substantial CAGR through 2032. This uptick is largely due to the increasing demand for easy consumer access. The digital shift in distribution not only simplifies the acquisition of home care testing products but also enhances user convenience and efficiency. To further bolster accessibility, online pharmacies are adopting features like real-time inventory updates, personalized recommendations, and direct-to-door delivery.

Regionally, the Europe home care testing market size is projected to depict a notable CAGR between 2024 and 2032, on account of the aging population and the rise in chronic diseases. As chronic conditions become more prevalent, there is a heightened demand for regular at-home testing and management. In response, companies are fine-tuning their home care testing products, ensuring users have the tools they need for effortless health monitoring. Furthermore, with advancements like sophisticated testing technologies and enhanced integration with digital health platforms, individuals in the region are better equipped to manage their health proactively.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of chronic diseases
  - 3.2.1.2 Growing demand for point of care testing
  - 3.2.1.3 Technological advancements in the products
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 High costs
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Pricing analysis, 2023
3.6 Technological landscape
3.7 Porter's analysis
3.8 PESTEL analysis
3.9 Future market trends
3.10 Gap analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Strip
5.3 Cassette
5.4 Test panel
5.5 Midstream
5.6 Dip card
5.7 Other product types

Chapter 6 Market Estimates and Forecast, By Test Type, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Infectious disease
6.3 Diabetes and glucose
6.4 HIV
6.5 Pregnancy
6.6 Cholesterol and triglycerides
6.7 Urinary tract infection
6.8 Other test types

Chapter 7 Market Estimates and Forecast, By Sample, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Blood
7.3 Urine
7.4 Saliva
7.5 Other samples

Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Retail pharmacies
8.3 Hospital pharmacies
8.4 Online pharmacies
8.5 Other distribution channels

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Italy
- 9.3.5 Spain
- 9.3.6 Netherlands
- 9.3.7 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 Saudi Arabia
- 9.6.2 South Africa
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa